<SEC-DOCUMENT>0001144204-19-003548-index.html : 20190129
<SEC-HEADER>0001144204-19-003548.hdr.sgml : 20190129
<ACCEPTANCE-DATETIME>20190129164659
ACCESSION NUMBER:		0001144204-19-003548
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190124
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
FILED AS OF DATE:		20190129
DATE AS OF CHANGE:		20190129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASI Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0000895051
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				581959440
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20713
		FILM NUMBER:		19549228

	BUSINESS ADDRESS:	
		STREET 1:		9620 MEDICAL CENTER DR
		STREET 2:		STE 300
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-864-2600

	MAIL ADDRESS:	
		STREET 1:		9620 MEDICAL CENTER DR
		STREET 2:		STE 300
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ENTREMED INC
		DATE OF NAME CHANGE:	19960415
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv511863_8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: tv511863_8k.htm

</DOCUMENT>
</SEC-DOCUMENT>